FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087940728> ?p ?o ?g. }

• W3087940728 endingPage "S1012" @default.
• W3087940728 startingPage "S1012" @default.
• W3087940728 abstract "Cancer patients (pts) have been associated with severe SARS-CoV2 infection and higher mortality compared with the general population. This could be related to the limitation of therapeutic effort based on their prognosis and healthcare prioritization towards non-cancer pts. The oncologist’s role could be crucial for providing high-quality care. We aim to assess the impact of oncologists (ONC) on COVID-19 management. Multicentre retrospective analysis of cancer pts diagnosed with COVID-19 between Mar-Apr 2020. We classified pts according to an estimated life expectancy (based on tumor/stage/line) in 3 groups: favourable group (FG) mOS >5 years (y), intermediate (IG) 1-5y and poor (PG) <1y. We studied COVID-19 management based on oncologist’s involvement: mainly-ONC vs. mainly other specialists (Other). Primary endpoint: COVID-19 30-day mortality (early-M). Secondary outcomes: intensive care unit admission (ICUa), the incidence of acute respiratory distress syndrome (ARDS) and antiretroviral treatment (ARVt) and immunomodulatory drugs (ImD) administered. 287 pts were enrolled, median age 69 (35-98), 52% male, 67% with an active tumor (of them 76% had advanced stage). Mostly thoracic tumors (26%), followed by gastrointestinal (21%) and breast (19%). Among 170 pts under treatment, 89 (52%) received chemotherapy (CHT). By prognostic group: 49% were included in FG (n=135), 40% in IG (n=113), and 11% in PG (n=30). Overall early-M rate was 27% (ONC 22% vs. Other 27%). Prognostic groups were associated with early-M: 19% (FG) vs. 31% (IG) vs. 37% (PG) (p=0.022). No significant differences regarding rate of ARDS (23% FG vs. 19% IG vs. 17% PG). The ONC-group (n=18) included 4 PG and 14 IG, 94% had an advanced stage disease, 83% receive CHT and 65% had PS≥2 (p=0.05 compared to Other group). In IG (ONC vs. Other): 7% vs. 2% ICUa, 100% vs. 34% ARVt and 57% vs. 7% ImD (all p<0.001). In PG (ONC vs. Other): 25% vs. 0% ICUa, 75% vs. 34% ARVt and 25% vs. 0% ImD (all p<0.001). Finally, FP managed only by Other: 13% ICUa; 33% ARVt and 13% ImD. Oncologist mostly treated complex pts compared to other specialists. During COVID-19 crisis, setting prognostic groups helped to individualized therapeutic approaches, reflected by less mortality rate and no differences in terms of complications." @default.
• W3087940728 created "2020-10-01" @default.
• W3087940728 creator A5001367507 @default.
• W3087940728 creator A5009978511 @default.
• W3087940728 creator A5012615559 @default.
• W3087940728 creator A5013805263 @default.
• W3087940728 creator A5014548131 @default.
• W3087940728 creator A5016310439 @default.
• W3087940728 creator A5016783216 @default.
• W3087940728 creator A5020674406 @default.
• W3087940728 creator A5038686648 @default.
• W3087940728 creator A5040733492 @default.
• W3087940728 creator A5043916639 @default.
• W3087940728 creator A5044580103 @default.
• W3087940728 creator A5055849397 @default.
• W3087940728 creator A5059519339 @default.
• W3087940728 creator A5073964596 @default.
• W3087940728 creator A5074054015 @default.
• W3087940728 creator A5087102723 @default.
• W3087940728 creator A5087643238 @default.
• W3087940728 creator A5090289526 @default.
• W3087940728 creator A5090587408 @default.
• W3087940728 date "2020-09-01" @default.
• W3087940728 modified "2023-10-01" @default.
• W3087940728 title "1726P Expanding the role of medical oncologist in the management of COVID-19" @default.
• W3087940728 doi "https://doi.org/10.1016/j.annonc.2020.08.1790" @default.
• W3087940728 hasPublicationYear "2020" @default.
• W3087940728 type Work @default.
• W3087940728 sameAs 3087940728 @default.
• W3087940728 citedByCount "2" @default.
• W3087940728 countsByYear W30879407282022 @default.
• W3087940728 countsByYear W30879407282023 @default.
• W3087940728 crossrefType "journal-article" @default.
• W3087940728 hasAuthorship W3087940728A5001367507 @default.
• W3087940728 hasAuthorship W3087940728A5009978511 @default.
• W3087940728 hasAuthorship W3087940728A5012615559 @default.
• W3087940728 hasAuthorship W3087940728A5013805263 @default.
• W3087940728 hasAuthorship W3087940728A5014548131 @default.
• W3087940728 hasAuthorship W3087940728A5016310439 @default.
• W3087940728 hasAuthorship W3087940728A5016783216 @default.
• W3087940728 hasAuthorship W3087940728A5020674406 @default.
• W3087940728 hasAuthorship W3087940728A5038686648 @default.
• W3087940728 hasAuthorship W3087940728A5040733492 @default.
• W3087940728 hasAuthorship W3087940728A5043916639 @default.
• W3087940728 hasAuthorship W3087940728A5044580103 @default.
• W3087940728 hasAuthorship W3087940728A5055849397 @default.
• W3087940728 hasAuthorship W3087940728A5059519339 @default.
• W3087940728 hasAuthorship W3087940728A5073964596 @default.
• W3087940728 hasAuthorship W3087940728A5074054015 @default.
• W3087940728 hasAuthorship W3087940728A5087102723 @default.
• W3087940728 hasAuthorship W3087940728A5087643238 @default.
• W3087940728 hasAuthorship W3087940728A5090289526 @default.
• W3087940728 hasAuthorship W3087940728A5090587408 @default.
• W3087940728 hasBestOaLocation W30879407281 @default.
• W3087940728 hasConcept C120665830 @default.
• W3087940728 hasConcept C121332964 @default.
• W3087940728 hasConcept C121608353 @default.
• W3087940728 hasConcept C126322002 @default.
• W3087940728 hasConcept C203092338 @default.
• W3087940728 hasConcept C2776348555 @default.
• W3087940728 hasConcept C2776376669 @default.
• W3087940728 hasConcept C2777714996 @default.
• W3087940728 hasConcept C2908647359 @default.
• W3087940728 hasConcept C535046627 @default.
• W3087940728 hasConcept C61511704 @default.
• W3087940728 hasConcept C71924100 @default.
• W3087940728 hasConcept C99454951 @default.
• W3087940728 hasConceptScore W3087940728C120665830 @default.
• W3087940728 hasConceptScore W3087940728C121332964 @default.
• W3087940728 hasConceptScore W3087940728C121608353 @default.
• W3087940728 hasConceptScore W3087940728C126322002 @default.
• W3087940728 hasConceptScore W3087940728C203092338 @default.
• W3087940728 hasConceptScore W3087940728C2776348555 @default.
• W3087940728 hasConceptScore W3087940728C2776376669 @default.
• W3087940728 hasConceptScore W3087940728C2777714996 @default.
• W3087940728 hasConceptScore W3087940728C2908647359 @default.
• W3087940728 hasConceptScore W3087940728C535046627 @default.
• W3087940728 hasConceptScore W3087940728C61511704 @default.
• W3087940728 hasConceptScore W3087940728C71924100 @default.
• W3087940728 hasConceptScore W3087940728C99454951 @default.
• W3087940728 hasLocation W30879407281 @default.
• W3087940728 hasLocation W30879407282 @default.
• W3087940728 hasOpenAccess W3087940728 @default.
• W3087940728 hasPrimaryLocation W30879407281 @default.
• W3087940728 hasRelatedWork W1580426574 @default.
• W3087940728 hasRelatedWork W2089620537 @default.
• W3087940728 hasRelatedWork W2275480158 @default.
• W3087940728 hasRelatedWork W2323950372 @default.
• W3087940728 hasRelatedWork W2371214482 @default.
• W3087940728 hasRelatedWork W2929987155 @default.
• W3087940728 hasRelatedWork W3095306390 @default.
• W3087940728 hasRelatedWork W4238089809 @default.
• W3087940728 hasRelatedWork W4288358222 @default.
• W3087940728 hasRelatedWork W4214780115 @default.
• W3087940728 hasVolume "31" @default.
• W3087940728 isParatext "false" @default.
• W3087940728 isRetracted "false" @default.
• W3087940728 magId "3087940728" @default.

• next